1. HOME
  2. 業績
  3. 業績
  4. Bibliography (英文論文) 2015年

業績

Reaserch result

業績

Bibliography (英文論文) 2015年

Bibliography (英文論文) 2015年

  1. Ikoma Y, Kijima H, Masuda R, Tanaka M, Inokuchi S, Iwazaki M. Podoplanin expression is correlated with the prognosis of lung squamous cell carcinoma. Biomed Res. 2015;36(6):393-402. doi: 10.2220/biomedres.36.393.
  2. Kimura Y, Morohashi S, Yoshizawa T, Suzuki T, Morohashi H, Sakamoto Y, Koyama M, Murata A, Kijima H, Hakamada K. Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer. Mol Med Rep. 2016 Feb;13(2):1551-7. doi: 10.3892/mmr.2015.4687. Epub 2015 Dec 17.
  3. Masuda D, Masuda R, Matsuzaki T, Imamura N, Aruga N, Tanaka M, Inokuchi S, Kijima H, Iwazaki M. Ki-67 labeling index affects tumor infiltration patterns of lung squamous cell carcinoma. Mol Med Rep. 2015 Nov;12(5):7303-9. doi: 10.3892/mmr.2015.4354.
  4. Tanaka M, Kijima H, Shimada H, Makuuchi H, Ozawa S, Inokuchi S. Expression of podoplanin and vimentin is correlated with prognosis in esophageal squamous cell carcinoma. Mol Med Rep. 2015 Sep;12(3):4029-36. doi: 10.3892/mmr.2015.3966.
  5. Seino H, Wu Y, Morohashi S, Kawamoto T, Fujimoto K, Kato Y, Takai Y, Kijima H. Basic helix-loop-helix transcription factor DEC1 regulates the cisplatin-induced apoptotic pathway of human esophageal cancer cells. Biomed Res. 2015;36(2):89-96. doi: 10.2220/biomedres.36.89.
  6. Sakuraba S, Morohashi S, Yoshizawa T, Tsutsumi S, Kimura K, Kudo D, Ishido K, Toyoki Y, Hakamada K, Kijima H. MUC5AC-negative phenotype is correlated with poor patient prognosis of pancreas head ductal carcinoma. Hirosaki Med J. 2015 Apr; 66: 28-37.
  7. Miyazaki M, Yoshitomi H, Miyakawa S, Uesaka K, Unno M, Endo I, Ota T, Ohtsuka M, Kinoshita H, Shimada K, Shimizu H, Tabata M, Chijiiwa K, Nagino M, Hirano S, Wakai T, Wada K, Iasayama H, Okusaka T, Tsuyuguchi T, Fujita N, Furuse J, Yamao K, Murakami K, Yamazaki H, Kijima H, Nakanuma Y, Yoshida M, Takayashiki T, Takada T. Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci. 2015 Apr;22(4):249-273. doi: 10.1002/jhbp.233. Epub 2015 Mar 18.
  8. Sawano T, Shimizu T, Yamada T, Nanashima N, Miura T, Morohashi S, Kudo D, Hui FM, Kijima H, Hakamada K, Tsuchida S. Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan. Oncol Rep. 2015 May;33(5):2151-60. doi: 10.3892/or.2015.3814. Epub 2015 Feb 20.
  9. Miyazaki M, Ohtsuka M, Miyakawa S, Nagino M, Yamamoto M, Kokudo N, Sano K, Endo I, Unno M, Chijiiwa K, Horiguchi A, Kinoshita H, Oka M, Kubota K, Sugiyama M, Uemoto S, Shimada M, Suzuki Y, Inui K, Tazuma S, Furuse J, Yanagisawa A, Nakanuma Y, Kijima H, Takada T. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition. J Hepatobiliary Pancreat Sci. 2015 Mar;22(3):181-196. doi: 10.1002/jhbp.211. Epub 2015 Feb 17.